REQUEST A DEMO
Total
USD $0.00
Search more companies

Cordlife Group Limited (Singapore)

Main Activities: Ambulatory Health Care Services
Full name: Cordlife Group Limited Profile Updated: November 01, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Cordlife Group Limited is engaged in providing umbilical cord blood and cord lining banking services. The company's services includes collection, processing, testing, cryo-preservation, and storage of child’s cord blood stem cells. Cordlife Group Limited owns and operates full processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia and The Philippines. The company was established in 2001 formerly known as CordLife Pte Ltd.

Legal Address
1 Yishun Industrial Street 1,A'Posh Bizhub,#06-01 / 09
Singapore; Singapore; Postal Code: 768160

Contact Details: Purchase the Cordlife Group Limited report to view the information.

Website: http://www.cordlife.com

Basic Information
Outstanding Shares:
Purchase the Cordlife Group Limited report to view the information.
Financial Auditors:
Purchase the Cordlife Group Limited report to view the information.
Incorporation Date:
2001
Key Executives
Purchase this report to view the information.
Board Member
Ownership Details
Purchase this report to view the information.
6.27%
Subsidiaries
Cell Care Australia Pty. Ltd. (Australia)
100%
Cordlife (Hong Kong) Limited (Hong Kong SAR, China)
100%
Cordlife Medical Phils, Inc. (Philippines)
100%
Company Performance
Financial values in the chart are available after Cordlife Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-20.84%
Total operating revenue
-20.61%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
83.41%
Total assets
8.65%
Total equity
11.75%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
5.7%
Return on Equity (ROE)
0.78%
Debt to Equity Ratio
2.67%
Quick Ratio
1.26%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?